CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		16 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Sep. 26, 2015
Cash flows from operating activities:
Net earnings	$ 34,171	$ 31,507
Adjustments to reconcile net earnings to net cash flows from operations:
Depreciation and amortization	20,598	23,901
Noncash loss on trading securities	995	4,415
Stock-based compensation	2,049	1,761
Defined benefit pension plan expense (benefit)	384	(150)
Contribution to defined benefit pension plan	0	(15,735)
Gain on sale of property, plant and equipment	144	(136)
Equity in earnings in nonconsolidated subsidiaries	0	0
Deferred income taxes	5,759	5,164
Changes in assets and liabilities:
Receivables	20,344	18,584
Inventories	(8,022)	(27,041)
Prepaid expenses	910	4,954
Accounts payable	1,383	(1,261)
Accrued expenses	(7,178)	(5,324)
Other noncurrent liabilities	(823)	1,684
Income taxes refundable	9,813	13,205
Net cash flows from operating activities	80,527	55,528
Cash flows from investing activities:
Purchase of property, plant and equipment	(13,961)	(16,615)
Proceeds from sale of assets	142	185
Other, net	(2,322)	2,930
Net cash flows from investing activities	(16,141)	(13,500)
Cash flows from financing activities:
Net borrowings under short-term agreements	1,352	1,155
Principal payments on long-term borrowings	(220)	(224)
Dividends paid	(8,571)	(9,086)
Dividends to noncontrolling interest	0	(1,290)
Purchase of treasury shares	(16,939)	(72,900)	$ (581,000)
Proceeds from exercises under stock plans	1,289	1,760
Excess tax benefits from stock option exercises	(66)	345
Purchase of common treasury shares—stock plan exercises	(219)	(2,156)
Net cash flows from financing activities	(23,374)	(82,396)
Effect of exchange rate changes on cash and cash equivalents	(2,372)	(12,845)
Net change in cash and cash equivalents	38,640	(53,213)
Cash and cash equivalents—beginning of year	349,074	371,579
Cash and cash equivalents—end of period	$ 387,714	$ 318,366